Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus + Trastuzumab + Vinorelbine for HER2+ Breast Cancer Brain Metastases
NCT01305941Phase 2Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Sep 2011
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in breast cancer, sponsored by UNC Lineberger Comprehensive Cancer Center. Started Sep 2011; status: completed.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01305941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01305941.